183 related articles for article (PubMed ID: 25732169)
21. Cost of cancer care: issues and implications.
Meropol NJ; Schulman KA
J Clin Oncol; 2007 Jan; 25(2):180-6. PubMed ID: 17210937
[TBL] [Abstract][Full Text] [Related]
22. Oncology issues in health care reform.
Kennedy BJ
Cancer Invest; 1994; 12(2):249-56. PubMed ID: 8131102
[No Abstract] [Full Text] [Related]
23. Case management: a tool for disease management programs.
Kozma CM
Manag Care Interface; 1999 Aug; 12(8):62, 64. PubMed ID: 10621095
[No Abstract] [Full Text] [Related]
24. Cancer in Botswana: resources and opportunities.
Suneja G; Ramogola-Masire D; Medhin HG; Dryden-Peterson S; Bekelman JE
Lancet Oncol; 2013 Jul; 14(8):e290-1. PubMed ID: 23816293
[No Abstract] [Full Text] [Related]
25. Funding Cancer Quality Improvement: Payer's Perspective.
Schumacher H
J Oncol Pract; 2015 May; 11(3):180-1. PubMed ID: 25804984
[No Abstract] [Full Text] [Related]
26. Provider Perspective on the Payer Perspective: What's in It for Me?
Stella PJ; Harrison KA
J Oncol Pract; 2015 May; 11(3):182-4. PubMed ID: 25804990
[No Abstract] [Full Text] [Related]
27. The imperative to address the cost of oncology care.
Meropol NJ
J Natl Cancer Inst; 2013 Dec; 105(23):1771-2. PubMed ID: 24226097
[No Abstract] [Full Text] [Related]
28. Cost-effectiveness, cancer burden and financial crisis: a perfect storm.
Belda-Iniesta C
Clin Transl Oncol; 2012 Oct; 14(10):713-4. PubMed ID: 22996423
[No Abstract] [Full Text] [Related]
29. Value-based payment models in oncology: will they help or hinder patient access to new treatments?
Shah S; Reh G
Am J Manag Care; 2017 Apr; 23(5 Spec No.):SP188-SP190. PubMed ID: 28665677
[No Abstract] [Full Text] [Related]
30. Innovative oncology products: time to revisit the strategy development?
Krendyukov A
ESMO Open; 2019; 4(5):e000571. PubMed ID: 31749992
[No Abstract] [Full Text] [Related]
31. The oncological package: a new source of concern in Poland's health system.
Holecki T; Romaniuk P
Lancet Oncol; 2015 Mar; 16(3):e104. PubMed ID: 25752556
[No Abstract] [Full Text] [Related]
32. Economic evaluation in radiology: reviewing the literature and examples in oncology.
Bresnahan BW
Acad Radiol; 2010 Sep; 17(9):1090-5. PubMed ID: 20634104
[TBL] [Abstract][Full Text] [Related]
33. Cost containment in health care: effects on American radiation oncology.
Griffin TW
Int J Radiat Oncol Biol Phys; 1994 Jul; 29(5):1187-8. PubMed ID: 8083089
[No Abstract] [Full Text] [Related]
34. Addressing the American health-care cost crisis: role of the oncology community.
Ramsey SD; Ganz PA; Shankaran V; Peppercorn J; Emanuel E
J Natl Cancer Inst; 2013 Dec; 105(23):1777-81. PubMed ID: 24226096
[TBL] [Abstract][Full Text] [Related]
35. Value-based reimbursement in oncology.
Kolodziej M; Hoverman JR
Am J Manag Care; 2012 May; 18(3 Spec No.):SP124-6. PubMed ID: 22642278
[No Abstract] [Full Text] [Related]
36. Why oncologists need technology to succeed in alternative payment models.
Fargnoli B; Holleran R; Kolodziej M
Am J Manag Care; 2017 Apr; 23(5 Spec No.):SP196-SP198. PubMed ID: 28665678
[No Abstract] [Full Text] [Related]
37. Comparative effectiveness research in oncology: the need for clarity, transparency and vision.
Lyman GH
Cancer Invest; 2009 Jul; 27(6):593-7. PubMed ID: 19557579
[No Abstract] [Full Text] [Related]
38. How should we pay the piper when he's calling the tune? On the long-term affordability of cancer care in the United States.
Ramsey SD
J Clin Oncol; 2007 Jan; 25(2):175-9. PubMed ID: 17210936
[No Abstract] [Full Text] [Related]
39. Why are we organizing another costing supplement in
Mittmann N
Curr Oncol; 2019 Apr; 26(2):87-88. PubMed ID: 31043807
[No Abstract] [Full Text] [Related]
40. Costs of cancer care: a view from the centers for Medicare and Medicaid services.
Bach PB
J Clin Oncol; 2007 Jan; 25(2):187-90. PubMed ID: 17210938
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
